Nirmatrelvir/ritonavir implementation in Canada : summary evaluation report : January to August 2022.: HP40-331/2023E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.919196&sl=0

Publication information
Department/Agency Public Health Agency of Canada, issuing body.
Title Nirmatrelvir/ritonavir implementation in Canada : summary evaluation report : January to August 2022.
Publication type Monograph
Language [English]
Other language editions [French]
Format Electronic
Electronic document
Note(s) Issued also in French under title: Mise en œuvre du nirmatrelvir/ritonavir au Canada : rapport d'évaluation sommaire : de janvier à août 2022.
"Pub.: 220700."
Includes bibliographical references.
Publishing information Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, February 2023.
©2023
Description 1 online resource (iv, 36 pages)
ISBN 9780660471129
Catalogue number
  • HP40-331/2023E-PDF
Departmental catalogue number 220700
Subject terms COVID-19 (Disease) -- Treatment -- Canada -- Evaluation.
Antiviral agents -- Therapeutic use -- Canada -- Evaluation.
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.
Report a problem or mistake on this page
Date modified: